CCCL [China Ceramics] 6-K: Contact Information: China Ceramics Co., Ltd. CCG Investor

[Contact Information: China Ceramics Co., Ltd. CCG Investor Relations Inc. Edmund Hen, Chief Financial Officer Mr. Ed Job, CFA - Account Manager Email: info@cceramics.com Email: ed.job@ccgir.com Phone: +1-646-213-1914 China Ceramics Announces Fourth Quarter and Fiscal Year 2010 Financial Results Jinjiang, Fujian Province, China, March 14, 2011 Fourth Quarter 2010 Highlights § Revenue was RMB 273.1 million (US$ 42.5 million), up] [Copy of correspondence to: Stuart Management Company 33 Riverside Avenue th 5 Westport, CT 06880 x ¨ Form 20-F ¨ ¨ ¨ x Yes Results of Operations and Financial Condition. Company On March 14, 2011, China Ceramics Co., Ltd. (the “ Description 99.1 Press release relating to financial results for the fourth quarter dated March 14, 2011]

By | 2016-03-21T19:37:45+00:00 March 18th, 2011|Categories: CCCL, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT March 14, 2010 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 3: Securities]

By | 2016-03-27T21:11:33+00:00 March 18th, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM

[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT March 14, 2010 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 3: Securities]

By | 2016-03-27T21:12:33+00:00 March 18th, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI 2010 Shareholder Annual Meeting on 3/21/11 to Be Held at 100 Wall Street, near NYSE TPI CHENGDU, China, March 17, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: The relocation is due to the most recent safety policy by NYSE that prevents any shareholder meetings to be arranged at NYSE. Shareholders who would like to attend the annual] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT March 17, 2010 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 8: Other]

By | 2016-03-27T21:14:03+00:00 March 18th, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI 2010 Shareholder Annual Meeting on 3/21/11 to

[TPI 2010 Shareholder Annual Meeting on 3/21/11 to Be Held at 100 Wall Street, near NYSE TPI CHENGDU, China, March 17, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: The relocation is due to the most recent safety policy by NYSE that prevents any shareholder meetings to be arranged at NYSE. Shareholders who would like to attend the annual] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT March 17, 2010 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 8: Other]

By | 2016-03-27T21:15:33+00:00 March 18th, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

NTES [NetEase] 6-K: (Original Filing)

[For further information contact: Lisa Jensen Vice President, Global Public Relations, Blizzard Entertainment 949.854.6200 dir 949.854.7900 fax ljensen@blizzard.com Rob Hilburger PR Director, Blizzard Entertainment 949.242.8404 dir 949.854.7900 fax rhilburger@blizzard.com Wu Wei PR Manager, NetEase 020-85106308 wuwei@corp.netease.com STARCRAFT OPEN BETA TESTING OF II IN MAINLAND CHINA STARTS ON MARCH29, 2011 SHANGHAI, China March18, 2011]

By | 2016-01-10T16:07:51+00:00 March 18th, 2011|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

NTES [NetEase] 6-K: For further information contact: Lisa Jensen Vice President,

[For further information contact: Lisa Jensen Vice President, Global Public Relations, Blizzard Entertainment 949.854.6200 dir 949.854.7900 fax ljensen@blizzard.com Rob Hilburger PR Director, Blizzard Entertainment 949.242.8404 dir 949.854.7900 fax rhilburger@blizzard.com Wu Wei PR Manager, NetEase 020-85106308 wuwei@corp.netease.com STARCRAFT OPEN BETA TESTING OF II IN MAINLAND CHINA STARTS ON MARCH29, 2011 SHANGHAI, China March18, 2011]

By | 2016-01-10T16:08:01+00:00 March 18th, 2011|Categories: Chinese Stocks, NTES, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: Mindray Appoints Mr.Jie Liu Chief Financial Officer Mr.Ronald

[Mindray Appoints Mr.Jie Liu Chief Financial Officer Mr.Ronald Ede Will Remain With Mindray a Director SHENZHEN, China, March18 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Mr. Jie Liu Chief Financial Officer (CFO)of thempany effective of April 30, 2011, succeeding Mr.Ronald]

Skip to toolbar